The Path of Discovery: From 'Me-Too Drugs' in Depression to Novel Rapid-Acting Therapeutics
Lipsett Auditorium, NIH Clinical Center (Building 10)
The Philip S. Chen, Jr., Ph.D., Distinguished Lecture on Innovation and Technology Transfer was established in 2006 by the NIH Deputy Director for Intramural Research and the NIH Office of Technology Transfer on the occasion of Dr. Chen’s retirement after over 41 years of service to the NIH. The lectureship honors Dr. Chen’s remarkable, diverse, and creative contributions to the NIH, especially to its Intramural Research Program and to the field of technology transfer.
This year, the 16th annual lecture in this series will be presented by Carlos A. Zarate, M.D., an NIH Distinguished Investigator and Chief of the Experimental Therapeutics & Pathophysiology Branch in the National Institute of Mental Health. Dr. Zarate's research focuses on developing novel medications for treatment-resistant depression and bipolar disorder. Among his accomplishment has been the demonstration of the drug ketamine as a rapid-acting antidepressant to reduce suicidal ideations when administered under carefully controlled clinical conditions.
This lecture also will be viewable online via NIH videocast.
This page was last updated on Tuesday, August 15, 2023